Thursday, June 11, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1177 of 1,261
  1. US 6582699

    Combination vaccine for enhancing immunity against brucellosis

    Her Majesty the Queen in right of Canada, as represented by the Minister of National Defence in her Brittanic Majesty's Government of the United Kingdom of Great Britain and Northern Ireland Β· Granted Jun 24, 2003 Β· Expires Jun 19, 2023

    expired
  2. US 6583146

    Thiazolopyrimidine compounds, its production and use

    Takeda Chemical Industries Ltd. Β· Granted Jun 24, 2003 Β· Expires Jun 19, 2023

    expired
  3. US 6583143

    CRF receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. Β· Granted Jun 24, 2003 Β· Expires Jun 19, 2023

    expired
  4. US 6583145

    Thio-oxindole derivatives

    Ligand Pharmaceuticals Incorporated Β· Granted Jun 24, 2003 Β· Expires Jun 19, 2023

    expired
  5. US 6583164

    Antimycotic drug composition

    Takeda Chemical Industries Ltd. Β· Granted Jun 24, 2003 Β· Expires Jun 19, 2023

    expired
  6. US 6583269

    Human protease inhibitor and polynucleotides encoding the same

    Lexicon Genetics, Inc. Β· Granted Jun 24, 2003 Β· Expires Jun 19, 2023

    expired
  7. US 6583271

    Use of thiol redox proteins for reducing protein intramolecular disulfide bonds, for improving the quality of cereal products, dough and baked goods and for inactivating snake, bee and scorpion toxins

    The Regents of the University of California Β· Granted Jun 24, 2003 Β· Expires Jun 19, 2023

    expired
  8. US 6579674

    Method for selective inactivation of viral replication

    Rigel Pharmaceuticals, Inc. Β· Granted Jun 17, 2003 Β· Expires Jun 12, 2023

    expired
  9. US 6579848

    Depigmenting activity of agouti signal protein and peptides thereof

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Jun 17, 2003 Β· Expires Jun 12, 2023

    expired
  10. US 6579893

    Use of troglitazone and related compounds for the treatment of cancer

    The Board of Regents of the University of Texas System Β· Granted Jun 17, 2003 Β· Expires Jun 12, 2023

    expired
  11. US 6579857

    Combination cancer therapy comprising adenosine and deaminase enzyme inhibitors

    EVANSTON NORTHWESTERN HEALTHCARE RESEARCH INSTITUTE Β· Granted Jun 17, 2003 Β· Expires Jun 12, 2023

    expired
  12. US 6579695

    Phosphopantetheinyl transferases and uses thereof

    The Regents of the University of California Β· Granted Jun 17, 2003 Β· Expires Jun 12, 2023

    expired
  13. US 6579684

    Assay of YKL-40 as a marker for cancer

    The Regents of the University of California Β· Granted Jun 17, 2003 Β· Expires Jun 12, 2023

    expired
  14. US 6579900

    Anandamide amidase inhibitors as analgesic agents

    UNIVERSITY OF CONNECTICUT Β· Granted Jun 17, 2003 Β· Expires Jun 12, 2023

    expired
  15. US 6576463

    Hybrid vectors for gene therapy

    The Regents of the University of California Β· Granted Jun 10, 2003 Β· Expires Jun 5, 2023

    expired
  16. US 6576791

    Local anesthetic compounds and uses

    Theravance, Inc. Β· Granted Jun 10, 2003 Β· Expires Jun 5, 2023

    expired
  17. US 6576609

    Methods and compositions for generating angiostatin

    Northwestern University Β· Granted Jun 10, 2003 Β· Expires Jun 5, 2023

    expired
  18. US 6576793

    &bgr;2-adrenergic receptor agonists

    Theravance, Inc. Β· Granted Jun 10, 2003 Β· Expires Jun 5, 2023

    expired
  19. US 6576786

    Process for preparing substituted cyclopentane derivatives and novel crystalline structures thereof

    BioCryst Pharmaceuticals, Inc. Β· Granted Jun 10, 2003 Β· Expires Jun 5, 2023

    expired
  20. US 6576764

    Synthesis and crystallization of piperazine ring-containing compounds

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Jun 10, 2003 Β· Expires Jun 5, 2023

    expired
  21. US 6576650

    Peripherally active anti-hyperalgesic opiates

    The Regents of the University of California Β· Granted Jun 10, 2003 Β· Expires Jun 5, 2023

    expired
  22. US 6576264

    Insoluble drug delivery

    The Board of Regents of the University of Texas System Β· Granted Jun 10, 2003 Β· Expires Jun 5, 2023

    expired
  23. US 6576155

    Fluorescent ink compositions comprising functionalized fluorescent nanocrystals

    BioCrystal, Ltd. Β· Granted Jun 10, 2003 Β· Expires Jun 5, 2023

    expired
  24. US 6576262

    Methods and apparatus for particle formation

    Nektar Therapeutics Β· Granted Jun 10, 2003 Β· Expires Jun 5, 2023

    expired

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.